Jin Yang Pharmaceutical   Report issue

For profit Phase 2
Founded: Seoul Korea, Republic of (1971)
Status: Left NME R&D (2008)

Organization Overview

First Clinical Trial
1998
NCT00329498
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
1998

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Leukemia (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Preleukemia (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1